About Christopher Cox
Christopher Cox is a director at Newsmax.
Form D filings also name Christopher Cox as a director at Alto Neuroscience.
Christopher Cox reports to the SEC as a director of 3 public companies, including Alto Neuroscience (ANRO) and High-Trend International Group (HTCO).
Christopher Cox first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Christopher Cox in the role, so the role may have started earlier or lasted longer.
HG
High-Trend International Group
Director
2026 · Public company (HTCO)
Key Colleagues at Startups
The people Christopher Cox works with at each company, as listed on that company's latest Form D.
Alto Neuroscience, Inc. · Form D, Oct 27, 2025
AS
Adam Savitz
Executive officer
AE
Amit Etkin
Executive officer and director
NS
Nicholas Smith
Chief Financial Officer and Chief Business Officer
GY
Gwill York
Director
HM
Husseini Manji
Director
RS
Raymond Sanchez
Director
AD
Andrew Dreyfus
Director
MH
Michael Hanley
Executive officer
Newsmax Inc. · Form D/A, Jun 20, 2024